Cancer treatment systems maker BSD Medical Corp (BSDM) has forged an exclusive distribution pact with Classic Medical Inc. (Classic Medical) for its MicroThermX Microwave Ablation system for soft tissue ablation (destruction).
Classic Medical is a leading distributor of minimally-invasive surgical products with a rich history of selling state-of-the-art surgical devices made by some of the major medical companies in the U.S. Moreover, the entity has long-term associations with doctors, key opinion leaders and hospitals across the Southeastern U.S.
Classic Medical has a dedicated sales force specialized in marketing surgical products for the interventional radiology market, the target area for BSD Medical’s ablation products. The deal provides it the rights to distribute the MicroThermX products in North Carolina, South Carolina, Georgia, Florida, Alabama and Tennessee.
The agreement concludes BSD Medical’s efforts to establish a dedicated specialty distribution network for the nationwide coverage of the MicroThermX products. The company has chosen the network of specialty distribution firms based on criteria such as sales mix and focus on interventional radiology.
BSD Medical, in May 2011, inked a distribution deal with Appleton Medical Services Inc. for the MicroThermX products. Moreover, the company recently entered into another agreement for the distribution of these products in the U.S.
BSD medical has also beefed up its sales and marketing force to support the roll-out of its MicroThermX products. The company now has a comprehensive marketing and sales team to oversee the nationwide distribution network, work together with sales representatives and offer training and clinical support.
The innovative MicroThermX systems were introduced in the U.S. in December 2010. Subsequently, the first MicroThermX system was successfully launched in Europe in January 2011.
The MicroThermX system uses BSD Medical’s proprietary synchronous phased array technology to deliver precision-guided microwave energy to ablate soft tissues using a single-patient-use disposable antenna.
The minimally-invasive MicroThermX system has been developed to provide treatments as a stand-alone therapy and has applications in open surgical and percutaneous (via needle-puncture of the skin) ablation procedures. As such, it can be used by both surgeons and interventional radiologists.
BSD Medical competes with established players like Boston Scientific (BSX) and Angiodynamics (ANGO) in the thermal ablation market. The global market potential for soft tissue ablation has been estimated to exceed $2.3 billion, offering a significant opportunity for BSD Medical.
ANGIODYNAMICS (ANGO): Free Stock Analysis Report
BOSTON SCIENTIF (BSX): Free Stock Analysis Report
Zacks Investment Research
